As of January 22, 2025, Adial Pharmaceuticals (ADIL) has a market cap of $6.242 million USD. According to our data, Adial Pharmaceuticals is ranked No.8993 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $6.24 M |
-4.55%
|
Dec 31, 2024 | $6.54 M |
-45.70%
|
Dec 29, 2023 | $12.04 M |
-66.18%
|
Dec 30, 2022 | $35.61 M |
-91.85%
|
Dec 31, 2021 | $0.44 B |
58.82%
|
Dec 31, 2020 | $0.28 B |
-29.46%
|
Dec 31, 2019 | $0.39 B |
-52.93%
|
Dec 31, 2018 | $0.83 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Alkermes
ALKS
|
$4.89 B |
-0.000 M
|
Ireland
|
BioXcel Therapeutics
BTAI
|
$18.04 M |
0.000 M
|
USA
|
Corcept Therapeutics
CORT
|
$6.18 B |
0.000 M
|
USA
|
Intra-Cellular Therapies
ITCI
|
$13.51 B |
-0.000 M
|
USA
|
Minerva Neurosciences
NERV
|
$14.76 M |
0.000 M
|
USA
|
Sage Therapeutics
SAGE
|
$0.43 B |
-0.000 M
|
USA
|
Supernus Pharmaceuticals
SUPN
|
$2.11 B |
-0.000 M
|
USA
|
Tonix Pharmaceuticals
TNXP
|
$59.62 M |
0.000 M
|
USA
|
Vanda Pharmaceuticals
VNDA
|
$0.25 B |
-0.000 M
|
USA
|
Axsome Therapeutics
AXSM
|
$4.96 B |
0.000 M
|
USA
|
Cassava Sciences
SAVA
|
$0.12 B |
0.000 M
|
USA
|
Relmada Therapeutics
RLMD
|
$11.76 M |
0.000 M
|
USA
|
VistaGen Therapeutics
VTGN
|
$83.25 M |
-0.000 M
|
USA
|
Market Cap | = | ADIL Stock Price | * | ADIL Shares Outstanding |
= | $0.96 | * | 6.47 M | |
= | $6.24 M |